Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & EnergyDetailed TOC of Global Drug Metabolism and Pharmacokinetics (DMPK) Market Research Report 2024
1 Report Overview1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Perspective (2019-2030)
2.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Growth Trends by Region
2.2.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drug Metabolism and Pharmacokinetics (DMPK) Historic Market Size by Region (2019-2024)
2.2.3 Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Region (2025-2030)
2.3 Drug Metabolism and Pharmacokinetics (DMPK) Market Dynamics
2.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Industry Trends
2.3.2 Drug Metabolism and Pharmacokinetics (DMPK) Market Drivers
2.3.3 Drug Metabolism and Pharmacokinetics (DMPK) Market Challenges
2.3.4 Drug Metabolism and Pharmacokinetics (DMPK) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Revenue
3.1.1 Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Revenue (2019-2024)
3.1.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Players (2019-2024)
3.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Metabolism and Pharmacokinetics (DMPK) Revenue
3.4 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Concentration Ratio
3.4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Metabolism and Pharmacokinetics (DMPK) Revenue in 2023
3.5 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK) Head office and Area Served
3.6 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Product and Application
3.7 Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Metabolism and Pharmacokinetics (DMPK) Breakdown Data by Type
4.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Historic Market Size by Type (2019-2024)
4.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Type (2025-2030)
5 Drug Metabolism and Pharmacokinetics (DMPK) Breakdown Data by Application
5.1 Global Drug Metabolism and Pharmacokinetics (DMPK) Historic Market Size by Application (2019-2024)
5.2 Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
6.2 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
6.4 North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
7.2 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
7.4 Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
8.2 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024)
8.4 Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
9.2 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
9.4 Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size (2019-2030)
10.2 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024)
10.4 Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Details
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.1.4 Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.1.5 Eurofins Discovery Recent Development
11.2 Inotiv
11.2.1 Inotiv Company Details
11.2.2 Inotiv Business Overview
11.2.3 Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.2.4 Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.2.5 Inotiv Recent Development
11.3 Evotec
11.3.1 Evotec Company Details
11.3.2 Evotec Business Overview
11.3.3 Evotec Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.3.4 Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.3.5 Evotec Recent Development
11.4 Sai Life Sciences
11.4.1 Sai Life Sciences Company Details
11.4.2 Sai Life Sciences Business Overview
11.4.3 Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.4.4 Sai Life Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.4.5 Sai Life Sciences Recent Development
11.5 Sygnature Discovery
11.5.1 Sygnature Discovery Company Details
11.5.2 Sygnature Discovery Business Overview
11.5.3 Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.5.4 Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.5.5 Sygnature Discovery Recent Development
11.6 WuXi AppTec
11.6.1 WuXi AppTec Company Details
11.6.2 WuXi AppTec Business Overview
11.6.3 WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.6.4 WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.6.5 WuXi AppTec Recent Development
11.7 Hangzhou Tigermed Consulting Co
11.7.1 Hangzhou Tigermed Consulting Co Company Details
11.7.2 Hangzhou Tigermed Consulting Co Business Overview
11.7.3 Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.7.4 Hangzhou Tigermed Consulting Co Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.7.5 Hangzhou Tigermed Consulting Co Recent Development
11.8 Q2 Solutions
11.8.1 Q2 Solutions Company Details
11.8.2 Q2 Solutions Business Overview
11.8.3 Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.8.4 Q2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.8.5 Q2 Solutions Recent Development
11.9 Jubilant Biosys
11.9.1 Jubilant Biosys Company Details
11.9.2 Jubilant Biosys Business Overview
11.9.3 Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.9.4 Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.9.5 Jubilant Biosys Recent Development
11.10 Frontage Laboratories
11.10.1 Frontage Laboratories Company Details
11.10.2 Frontage Laboratories Business Overview
11.10.3 Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.10.4 Frontage Laboratories Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.10.5 Frontage Laboratories Recent Development
11.11 Invitrocue
11.11.1 Invitrocue Company Details
11.11.2 Invitrocue Business Overview
11.11.3 Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.11.4 Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.11.5 Invitrocue Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Details
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.12.4 Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.12.5 Creative Biolabs Recent Development
11.13 CrownBioscience
11.13.1 CrownBioscience Company Details
11.13.2 CrownBioscience Business Overview
11.13.3 CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.13.4 CrownBioscience Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.13.5 CrownBioscience Recent Development
11.14 Agilent
11.14.1 Agilent Company Details
11.14.2 Agilent Business Overview
11.14.3 Agilent Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.14.4 Agilent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.14.5 Agilent Recent Development
11.15 H3D
11.15.1 H3D Company Details
11.15.2 H3D Business Overview
11.15.3 H3D Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.15.4 H3D Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.15.5 H3D Recent Development
11.16 LABCORP
11.16.1 LABCORP Company Details
11.16.2 LABCORP Business Overview
11.16.3 LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.16.4 LABCORP Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.16.5 LABCORP Recent Development
11.17 Bioduro-Sundia
11.17.1 Bioduro-Sundia Company Details
11.17.2 Bioduro-Sundia Business Overview
11.17.3 Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.17.4 Bioduro-Sundia Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.17.5 Bioduro-Sundia Recent Development
11.18 Allucent
11.18.1 Allucent Company Details
11.18.2 Allucent Business Overview
11.18.3 Allucent Drug Metabolism and Pharmacokinetics (DMPK) Introduction
11.18.4 Allucent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
11.18.5 Allucent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Figures, Tables and Charts Available in Global Drug Metabolism and Pharmacokinetics (DMPK) Market Research Report 2024
List of TablesTable 1. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Small Molecules
Table 3. Key Players of Biologics
Table 4. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region (2019-2024)
Table 8. Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region (2025-2030)
Table 10. Drug Metabolism and Pharmacokinetics (DMPK) Market Trends
Table 11. Drug Metabolism and Pharmacokinetics (DMPK) Market Drivers
Table 12. Drug Metabolism and Pharmacokinetics (DMPK) Market Challenges
Table 13. Drug Metabolism and Pharmacokinetics (DMPK) Market Restraints
Table 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Players (2019-2024)
Table 16. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Metabolism and Pharmacokinetics (DMPK) as of 2023)
Table 17. Ranking of Global Top Drug Metabolism and Pharmacokinetics (DMPK) Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Headquarters and Area Served
Table 20. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Product and Application
Table 21. Global Key Players of Drug Metabolism and Pharmacokinetics (DMPK), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Type (2019-2024)
Table 25. Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Type (2025-2030)
Table 27. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Application (2019-2024)
Table 29. Global Drug Metabolism and Pharmacokinetics (DMPK) Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Drug Metabolism and Pharmacokinetics (DMPK) Revenue Market Share by Application (2025-2030)
Table 31. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Country (2025-2030) & (US$ Million)
Table 46. Eurofins Discovery Company Details
Table 47. Eurofins Discovery Business Overview
Table 48. Eurofins Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 49. Eurofins Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 50. Eurofins Discovery Recent Development
Table 51. Inotiv Company Details
Table 52. Inotiv Business Overview
Table 53. Inotiv Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 54. Inotiv Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 55. Inotiv Recent Development
Table 56. Evotec Company Details
Table 57. Evotec Business Overview
Table 58. Evotec Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 59. Evotec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 60. Evotec Recent Development
Table 61. Sai Life Sciences Company Details
Table 62. Sai Life Sciences Business Overview
Table 63. Sai Life Sciences Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 64. Sai Life Sciences Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 65. Sai Life Sciences Recent Development
Table 66. Sygnature Discovery Company Details
Table 67. Sygnature Discovery Business Overview
Table 68. Sygnature Discovery Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 69. Sygnature Discovery Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 70. Sygnature Discovery Recent Development
Table 71. WuXi AppTec Company Details
Table 72. WuXi AppTec Business Overview
Table 73. WuXi AppTec Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 74. WuXi AppTec Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 75. WuXi AppTec Recent Development
Table 76. Hangzhou Tigermed Consulting Co Company Details
Table 77. Hangzhou Tigermed Consulting Co Business Overview
Table 78. Hangzhou Tigermed Consulting Co Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 79. Hangzhou Tigermed Consulting Co Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 80. Hangzhou Tigermed Consulting Co Recent Development
Table 81. Q2 Solutions Company Details
Table 82. Q2 Solutions Business Overview
Table 83. Q2 Solutions Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 84. Q2 Solutions Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 85. Q2 Solutions Recent Development
Table 86. Jubilant Biosys Company Details
Table 87. Jubilant Biosys Business Overview
Table 88. Jubilant Biosys Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 89. Jubilant Biosys Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 90. Jubilant Biosys Recent Development
Table 91. Frontage Laboratories Company Details
Table 92. Frontage Laboratories Business Overview
Table 93. Frontage Laboratories Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 94. Frontage Laboratories Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 95. Frontage Laboratories Recent Development
Table 96. Invitrocue Company Details
Table 97. Invitrocue Business Overview
Table 98. Invitrocue Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 99. Invitrocue Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 100. Invitrocue Recent Development
Table 101. Creative Biolabs Company Details
Table 102. Creative Biolabs Business Overview
Table 103. Creative Biolabs Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 104. Creative Biolabs Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 105. Creative Biolabs Recent Development
Table 106. CrownBioscience Company Details
Table 107. CrownBioscience Business Overview
Table 108. CrownBioscience Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 109. CrownBioscience Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 110. CrownBioscience Recent Development
Table 111. Agilent Company Details
Table 112. Agilent Business Overview
Table 113. Agilent Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 114. Agilent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 115. Agilent Recent Development
Table 116. H3D Company Details
Table 117. H3D Business Overview
Table 118. H3D Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 119. H3D Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 120. H3D Recent Development
Table 121. LABCORP Company Details
Table 122. LABCORP Business Overview
Table 123. LABCORP Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 124. LABCORP Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 125. LABCORP Recent Development
Table 126. Bioduro-Sundia Company Details
Table 127. Bioduro-Sundia Business Overview
Table 128. Bioduro-Sundia Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 129. Bioduro-Sundia Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 130. Bioduro-Sundia Recent Development
Table 131. Allucent Company Details
Table 132. Allucent Business Overview
Table 133. Allucent Drug Metabolism and Pharmacokinetics (DMPK) Product
Table 134. Allucent Revenue in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024) & (US$ Million)
Table 135. Allucent Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
Table 139. Authors List of This Report
List of Figures
Figure 1. Drug Metabolism and Pharmacokinetics (DMPK) Picture
Figure 2. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Type: 2023 VS 2030
Figure 4. Small Molecules Features
Figure 5. Biologics Features
Figure 6. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Application: 2023 VS 2030
Figure 8. Biopharmaceutical Companies Case Studies
Figure 9. Government and Academic Institutes Case Studies
Figure 10. Others Case Studies
Figure 11. Drug Metabolism and Pharmacokinetics (DMPK) Report Years Considered
Figure 12. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region: 2023 VS 2030
Figure 15. Global Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Players in 2023
Figure 16. Global Top Drug Metabolism and Pharmacokinetics (DMPK) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Metabolism and Pharmacokinetics (DMPK) as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Drug Metabolism and Pharmacokinetics (DMPK) Revenue in 2023
Figure 18. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Country (2019-2030)
Figure 20. United States Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Country (2019-2030)
Figure 24. Germany Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Region (2019-2030)
Figure 32. China Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Country (2019-2030)
Figure 40. Mexico Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Drug Metabolism and Pharmacokinetics (DMPK) Market Share by Country (2019-2030)
Figure 44. Turkey Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Drug Metabolism and Pharmacokinetics (DMPK) Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Eurofins Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 48. Inotiv Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 49. Evotec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 50. Sai Life Sciences Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 51. Sygnature Discovery Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 52. WuXi AppTec Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 53. Hangzhou Tigermed Consulting Co Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 54. Q2 Solutions Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 55. Jubilant Biosys Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 56. Frontage Laboratories Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 57. Invitrocue Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 58. Creative Biolabs Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 59. CrownBioscience Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 60. Agilent Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 61. H3D Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 62. LABCORP Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 63. Bioduro-Sundia Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 64. Allucent Revenue Growth Rate in Drug Metabolism and Pharmacokinetics (DMPK) Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
REQUEST COMPANIES MENTIONED IN THIS REPORT
